Vanguard Group Inc Biomarin Pharmaceutical Inc Transaction History

Vanguard Group Inc

  • $6.44 Trillion
  • Q3 2025

A detailed history of Vanguard Group Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Vanguard Group Inc holds 18,582,585 shares of BMRN stock, worth $1.02 Billion. This represents 0.02% of its overall portfolio holdings.

Number of Shares
18,582,585
Previous 19,003,832 2.22%
Holding current value
$1.02 Billion
Previous $1.04 Billion 3.66%
% of portfolio
0.02%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
SELL
$52.62 - $61.93 $22.2 Million - $26.1 Million
-421,247 Reduced 2.22%
18,582,585 $1.01 Billion
Q2 2025

Aug 11, 2025
BUY
$54.08 - $68.32 $33,529 - $42,358
620 Added 0.0%
19,003,832 $1.04 Billion
Q1 2025

May 09, 2025
SELL
$61.25 - $72.83 $22.6 Million - $26.9 Million
-368,973 Reduced 1.9%
19,003,212 $1.34 Billion
Q4 2024

Feb 11, 2025
BUY
$61.93 - $70.49 $5.79 Million - $6.59 Million
93,531 Added 0.49%
19,372,185 $1.27 Billion
Q3 2024

Nov 13, 2024
BUY
$69.02 - $93.84 $19.6 Million - $26.7 Million
284,616 Added 1.5%
19,278,654 $1.36 Billion
Q2 2024

Aug 13, 2024
BUY
$74.43 - $92.22 $65.3 Million - $80.9 Million
876,930 Added 4.84%
18,994,038 $1.56 Billion
Q1 2024

May 10, 2024
BUY
$83.81 - $99.0 $5.62 Million - $6.64 Million
67,046 Added 0.37%
18,117,108 $1.58 Billion
Q4 2023

Feb 14, 2024
BUY
$76.22 - $98.51 $26.6 Million - $34.4 Million
348,852 Added 1.97%
18,050,062 $1.74 Billion
Q3 2023

Nov 14, 2023
SELL
$85.07 - $94.48 $3.44 Million - $3.83 Million
-40,496 Reduced 0.23%
17,701,210 $1.57 Billion
Q2 2023

Aug 14, 2023
BUY
$86.68 - $100.3 $18.1 Million - $20.9 Million
208,460 Added 1.19%
17,741,706 $1.54 Billion
Q1 2023

Jul 14, 2023
BUY
$87.74 - $117.27 $131,610 - $175,905
1,500 Added 0.01%
17,533,246 $1.7 Billion
Q1 2023

May 15, 2023
BUY
$87.74 - $117.27 $14.6 Million - $19.5 Million
166,666 Added 0.96%
17,531,746 $1.7 Billion
Q4 2022

Feb 10, 2023
BUY
$80.93 - $108.63 $20.8 Million - $27.9 Million
256,791 Added 1.5%
17,365,080 $1.8 Billion
Q3 2022

Nov 14, 2022
BUY
$82.16 - $96.94 $21.6 Million - $25.5 Million
263,453 Added 1.56%
17,108,289 $1.45 Billion
Q2 2022

Aug 12, 2022
BUY
$71.48 - $86.85 $24.5 Million - $29.8 Million
342,593 Added 2.08%
16,844,836 $1.4 Billion
Q1 2022

May 13, 2022
BUY
$74.28 - $92.69 $11.2 Million - $14 Million
151,212 Added 0.92%
16,502,243 $1.27 Billion
Q4 2021

Feb 14, 2022
BUY
$71.72 - $91.47 $3.19 Million - $4.07 Million
44,474 Added 0.27%
16,351,031 $1.44 Billion
Q3 2021

Nov 12, 2021
BUY
$74.77 - $85.47 $6.28 Million - $7.18 Million
83,963 Added 0.52%
16,306,557 $1.26 Billion
Q2 2021

Aug 13, 2021
BUY
$75.51 - $84.79 $1.22 Billion - $1.38 Billion
16,222,594 New
16,222,594 $1.35 Billion

Others Institutions Holding BMRN

# of Institutions
669
Shares Held
182M
Call Options Held
1.52M
Put Options Held
1.01M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $10.2B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email